Hepatitis C Management in Special Populations

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 8/17/18 (What's New)

Introduction

  • HCV is a major cause of cirrhosis and hepatocellular carcinoma worldwide[Ponziani 2011]
  • In the US, HCV is a leading cause of liver-related death and the most common indication for liver transplantation[Fayek 2016; CDC HCV FAQ]
  • Effective HCV therapies are available; the presence of comorbidities, coinfections, and other special patient circumstances may complicate their use in clinical practice

HCV is a leading cause of cirrhosis and hepatocellular carcinoma across the globe.[Ponziani 2011] With an estimated 71 million people chronically infected worldwide and approximately 399,000 HCV-related deaths each year,[WHO HCV]...

Action required

Keywords: Hepatitis C